Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Polymyositis Stories

2013-05-29 08:30:06

ANAHEIM, Calif., May 29, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that its Board of Directors has declared a quarterly cash dividend of $0.25 per share to shareholders of record at the close of business on July 22, 2013. The dividend is scheduled to be paid on or about July 30, 2013. About Questcor Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat...

2013-05-08 16:27:50

ANAHEIM, Calif., May 8, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas on May 14, 2013 at 4:20 PM PT/7:20 PM ET. A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay will be available for approximately 90 days after the event. About Questcor...

2013-04-15 08:27:56

ANAHEIM, Calif., April 15, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release first quarter 2013 financial results on Tuesday, April 30, 2013 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, April 30, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the quarter, as well as current corporate developments. The call can be...

2013-02-06 16:26:29

ANAHEIM, Calif., Feb. 6, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release fourth quarter and full year 2012 financial results on Tuesday, February 26, 2013 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, February 26, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the quarter and full year, as well as current...

2012-09-13 02:26:49

ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis. "Questcor is very pleased to be able to make this commitment to The Myositis Association and the dermatomyositis and polymyositis communities," said Steve Cartt, Chief Operating Officer of Questcor. "Further research into these...

2012-06-14 10:23:03

ANAHEIM, Calif., June 14, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced key elements of the Company's initial commercialization plans for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of rheumatology-related indications already included on the FDA-approved package insert for Acthar. Acthar is indicated for multiple FDA-approved rheumatology-related conditions, including its use as adjunctive therapy in psoriatic arthritis,...

2012-06-11 06:24:38

ANAHEIM, Calif., June 11, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will host an analyst and investor conference call on Thursday, June 14, 2012 at 1:30 p.m. PDT / 4:30 p.m. EDT to review the Company's commercialization strategy for H.P. Acthar® Gel (repository corticotropin injection) for the following rheumatology-related FDA-approved indications on the label for Acthar: Collagen Diseases: "during an exacerbation or as maintenance...

2011-11-28 22:50:14

In a nationwide study based on data from the in-patient register, researchers have studied the risk of a blood clot on the lung for patients with autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease and type 1 diabetes. The study showed that 31 of the 33 autoimmune diseases studied were associated with an increased risk of pulmonary embolism — a blood clot on the lung. Autoimmune diseases, in which the immune system attacks the body, are fairly common. Thyroid...

2011-01-06 09:36:16

(Ivanhoe Newswire) -- Autoimmune interstitial lung disease (ILD) is, in most cases, irreversible. A new study shows that a vitamin D deficiency could be linked to the development and severity of autoimmune ILD. Brent Kinder, M.D., a pulmonologist and director of the Interstitial Lung Disease Center at the University of Cincinnati, says vitamin D deficiencies have been found to affect the development of other autoimmune diseases such as lupus and type 1 diabetes. "We wanted to see if lack of...

2011-01-04 13:24:07

A new study shows that vitamin D deficiency could be linked to the development and severity of certain autoimmune lung diseases. These findings are being reported in the Jan. 4 edition of the journal Chest. Brent Kinder, MD, UC Health pulmonologist, director of the Interstitial Lung Disease Center at the University of Cincinnati and lead investigator on the study, says vitamin D deficiencies have been found to affect the development of other autoimmune diseases, like lupus and type 1...